Co-prescription of metoprolol and CYP2D6-inhibiting antidepressants before and after implementation of an optimized drug interaction database in Norway

PURPOSE: To compare the co-prescription of metoprolol and potent CYP2D6-inhibiting antidepressants before and during a 10-year period after implementation of an optimized drug interaction database into clinical decision support systems in Norway. METHODS: The study was a retrospective, cross-sequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Gedde-Dahl, Ane, Spigset, Olav, Molden, Espen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482580/
https://www.ncbi.nlm.nih.gov/pubmed/35871665
http://dx.doi.org/10.1007/s00228-022-03364-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482580/
https://www.ncbi.nlm.nih.gov/pubmed/35871665
http://dx.doi.org/10.1007/s00228-022-03364-5

Ejemplares similares